Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.
about
Positron emission tomography imaging of prostate cancerInternational Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesBombesin-related peptides and their receptors: recent advances in their role in physiology and disease statesProstate cancer relevant antigens and enzymes for targeted drug deliveryInsights into bombesin receptors and ligands: Highlighting recent advancesIntracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.Design and applications of bispecific heterodimers: molecular imaging and beyond(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.LC/MS evaluation of metabolism and membrane transport of bombesin peptides.Vaccines targeting the neovasculature of tumorsMolecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice.Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1αTranscriptomic analysis of the lesser spotted catshark (Scyliorhinus canicula) pancreas, liver and brain reveals molecular level conservation of vertebrate pancreas function.Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophilsDevelopment of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.Gastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression.Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS.Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target.Cancer treatment using peptides: current therapies and future prospectsAnatomy and neurophysiology of pruritus.Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesEvaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.The delivery of therapeutic oligonucleotidesSpecific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vivo.Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cellsCellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted deliveryRole of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.Current and emerging molecular targets in glioma.Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases.Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.Targeted prodrug approaches for hormone refractory prostate cancer.Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer.Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer.(18)F-click labeling of a bombesin antagonist with an alkyne-(18)F-ArBF(3) (-): in vivo PET imaging of tumors expressing the GRP-receptor
P2860
Q24596241-D61A4D3B-D3A2-4C6E-984C-B359D4F85FA0Q24643524-3E71F871-0750-4294-95A6-7ADE2822873AQ24645097-DCD95F44-F80E-4C78-8CE0-8E792895EEF0Q27013843-82029F7F-1D3C-4E84-8414-821CA7CD9622Q28081153-9190FCDF-7057-4DB8-BDA7-733CC9D3EA74Q30434397-1B07FC09-6B6A-4055-A2F0-1ECDBC297A93Q33732587-2814BE20-A361-49E2-8E80-77AE470F2C62Q33956262-260AD232-433F-4AE1-BC4B-4AD36C31952BQ34490275-F2263ABF-7B5A-47EF-A8C3-994181F90CF8Q34704905-1A8172DD-C6D9-42F5-BFCA-F2CA968BB414Q35031696-B4DBA9CE-B8CC-4F3F-B448-E35465954707Q35070598-6798960E-4BAE-4798-AA74-3B3E7042D62EQ35185531-EA302EA9-45DA-4C10-AC5C-6FE5267B475BQ35673725-331FFCF6-93A7-4919-B05D-F6A71A220F00Q35846757-CF8E6EDB-FE3A-4DFD-B87F-3A9A790820FDQ36067344-7F8C4E67-A11C-4D50-A9C7-B41B85C5F7E7Q36069546-502D40FC-739B-47A9-8C53-E4D31403FF8CQ36469594-C38DA2B6-46DA-4BA0-9040-CF41786C29FAQ36515785-576945BD-B035-4FD9-8993-BBF81B5C4884Q36960447-F4625C47-C846-43F4-A1D0-7CA70777E4DDQ37015817-AC612017-5F56-470E-9910-4EAA64ACDE1CQ37109589-7238E5CC-6FDA-453D-B6B2-8E7CAF597BE3Q37210936-99593ABE-65C1-4F8B-8B1F-2982B6DD293EQ37256078-116F595A-AE6D-4F7B-B62D-345E2BA41FCAQ37641064-50FCCA96-7618-442A-9AE2-C9DBFF7E8806Q37656119-902BDEDE-9397-4BC9-A0A0-077EE0DE03D5Q37729818-DBB00119-DFCA-4956-98B7-77FB7471C83EQ37800506-A8D826C4-1BE8-4ACC-BCF8-F8B879BC72ECQ37809861-CC00ABE0-745B-4B60-BDAA-AF2EED7422DCQ38096994-A48712A3-AB63-4CF7-9B9C-A7279B124708Q38269032-5E2B5870-C36B-46D6-BDD5-AE262475AF5EQ38295983-FBC65662-2FD0-4B88-84A0-210F22281955Q38704284-E0FE4EB4-67EB-4788-AD80-0E30DC31F81BQ38740306-FF77E382-1086-4994-A964-158DF47FFAA0Q38817974-F61A695A-FE83-46D5-8EAE-4E287D9BA654Q38834893-9BAAD253-6E62-4362-AD1C-EE8E915D804BQ38979450-B29515F8-215D-4F5B-9403-8DE55B464C69Q39378866-6B9EA4A2-CF4C-4ABD-83C9-A26B3345D9D6Q39562114-0DE8B37E-84D7-4B42-9B0D-D3226E015682Q41871389-D5C77849-FDFD-41C3-9FE4-1AE95C994413
P2860
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@ast
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@en
type
label
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@ast
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@en
prefLabel
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@ast
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@en
P2093
P356
P1433
P1476
Gastrin-releasing peptide rece ...... perimental anticancer therapy.
@en
P2093
D B Cornelio
G Schwartsmann
P304
P356
10.1093/ANNONC/MDM058
P577
2007-03-09T00:00:00Z